Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Resverlogix Corp T.RVX

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  RVXCF

Resverlogix Corp is a clinical stage cardiovascular company. It is engaged in developing small molecules that selectively inhibit Bromodomain and ExtraTerminal domain (BET) proteins, a new and emerging target for high risk vascular diseases.
Price: $0.82 | Change: $-0.05 | %Change: -5.75%
Volume: 236,144 | Day High/Low: 0.88/0.75 | 52 Week High/Low: 1.00/0.405
View modes: 
0 stars

RE:zenith

anthony: .....You are correct...... The "Assignment and Services Agreement "(i.e. the services), allows this sort of ongoing fiasco between the 2 entities.  But does it make it right for Zenith not to...read more
0 stars

zenith

It is perfectly legal for RVX to extend a loan to Zenith.I believe the terms should be reflected in the statements.Zenith will at sometime repay the loan from financing from another source.I would...read more
0 stars

RE:RE:RE:zenith

Hey Jkj, Gv, Anthonyevens. About a year ago in one of my frustrated posts I mentioned about Canada's wild west stock exchanges (Vancouver SE and Alberta SE) that were notorious for the dirty trading,...read more
5 stars

RE:zenith cash

Thanks anthonyevens. Interesting point and it makes sense to me. Zenith certainly has no concern at all about financing however they get it. I'm just doing a think out loud recall of events. So...read more
0 stars

RE:RE:zenith

Without question, GV. How can it not be a conflict when the BD's are identical, as are the CIO's, and the shareholders have, in no way consented to this patent conflict of interest or amy waiver...read more
5 stars

RE:zenith

Yes anthony ...that's about it....However RVX shareholders should not be footing the bill for Zenith.  I find this to be a conflict of interest.  JMO G1945V  rate and reply
5 stars

zenith

You will note that on the Dec 11th filing they had just over a million owing from Zenith I expect this t0 be close to 2mill Mar 12th  rate and reply
5 stars

zenith cash

Last month I asked about the cash and was told that they had ways to finance,this is obvious.What they would not say is how they were doing it.They could not release info to individuals.The only...read more
0 stars

RE:RE:PP for Zenith??

Yes they did . The $10M was part of the deal with SPINCO. But that money is long gone. G1945V  rate and reply
5 stars

Support at the 20 day moving average...

Here's the chart....note the rising level of support around the 20 dma, and also the fast approaching golden cross with the 50 dma poised to cross over the 200.  I prefer stockcharts.com but I can't...read more
0 stars

RE:PP for Zenith??

Did they not move about $10,000,000 over from RVX about 2 years back if that?  rate and reply
0 stars

PP for Zenith??

By now there should  have been a Private Placement announcment for Zenith for badly needed funds. How are they maintaining operations..?? Strange indeed?? Waiting for KD and NGN I guess,...... the...read more
0 stars

Added.....

Sometimes you have to have the courage of your convictions.  rate and reply
0 stars

RE:Volatility

I figured .80 was the bounce point but nothing would suprise me...even another test of more recen lows.  rate and reply
0 stars

RE:Volatility

rony: I am sure day traders are making a bit of hay if they bought in at tax selling season at 40+ cents and sell off at 80+ cents.   :) JMO G1945V  rate and reply
0 stars

Volatility

......never stops with this stock!  rate and reply
3 stars

NOVARTIS NEW CARDIO DRUG- AD CONCERN

For those of interest: SPOTLIGHT ON... Novartis looks to squelch neuro worries over its would-be cardio blockbuster Novartis ($NVS), at work on a cardio drug widely expected to bring in...read more
0 stars

RE:a map of the epigenome

Hi Jkj. Thanks for the post. I'd like to hear from the science posters if possible regarding the implications for Zenith. Perhaps it will help Zenith get moving on some progress. The big boys (and...read more
4.5 stars

a map of the epigenome

FOR THOSE OF INTEREST: A massive data generation and analysis program has uncovered a map of the epigenome, the switches that turn genes off and on. Researchers published their findings in a series...read more
0 stars

RE:Insider activity,,,,,,,,,,,,,,,,

Hello narmac: The only one that bought from the public market is Johansson. Some presumably forfieted (RSU's)Restriucted Share Ownership ( shown in red- negative) ??? Some gained restrcted share...read more